DEEP VEIN THROMBOSIS Clinical Trial
Official title:
Intensivist Performed Limited B Mode Compression Ultrasound for Diagnosis of Deep Vein Thrombosis in the Intensive Care Unit
We propose an observational study to assess the ability of intensivists to evaluate for deep vein thrombosis using 2 point compression ultrasonography.
Status | Terminated |
Enrollment | 150 |
Est. completion date | May 2015 |
Est. primary completion date | May 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Male and female adults at least 18 years of age - Duplex ultrasonography ordered by treating team - Admission to the Medical, Cardiac, Burn, or Surgical intensive care units Exclusion Criteria: - Patients less than 18 years of age - Patients with a known current DVT - patients on whom the exam cannot be performed (above the knee amputation, severe cellulitis of groin or popliteal fossa, hip or knee fracture) |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | University of missouri healthcare | Columbia | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Missouri-Columbia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The agreement between physician performed ultrasound and formal duplex ultrasonography for detection of proximal deep vein thrombosis. | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: location of thrombus (proximal or distal) | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: number of days in the hospital prior to exam | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: body mass index (BMI) | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: weight gain from admission to the time of the exam | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: training level of examiner | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: difficulty of exam | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: specific examiner | 48 hours window from detailed US | No | |
Secondary | Subgroup analysis: presence or absence of calf vein thrombosis | at study conclusion | No | |
Secondary | Subgroup analysis: presence or absence of pulmonary embolism | at study conclusion | No | |
Secondary | Subgroup analysis: DVT location | at study conclusion | No | |
Secondary | Subgroup analysis: calf vein thrombosis | at study conclusion | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05003843 -
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
|
N/A | |
Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
Withdrawn |
NCT04136561 -
Novel Strategy to Encourage Early Removal of Central Venous Catheters
|
N/A | |
Completed |
NCT03420625 -
Blood Flow Stimulation in the Lower Limbs by Application of Different External Devices
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02555111 -
Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
|
Phase 3 | |
Terminated |
NCT02469376 -
Evaluation of a New Imagingtechnologie for Thrombosis
|
Phase 1 | |
Completed |
NCT01975090 -
The SENTRY Clinical Study
|
N/A | |
Completed |
NCT02037607 -
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
|
N/A | |
Not yet recruiting |
NCT01357941 -
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
|
N/A | |
Completed |
NCT00771303 -
Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
|
||
Completed |
NCT00773448 -
Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism
|
N/A | |
Completed |
NCT00720915 -
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
|
N/A | |
Completed |
NCT00244725 -
Odiparcil For The Prevention Of Venous Thromboembolism
|
Phase 2 | |
Completed |
NCT00264277 -
D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
|
Phase 4 | |
Completed |
NCT00365950 -
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
|
Phase 4 | |
Completed |
NCT00182403 -
Fixed Dose Heparin Study
|
Phase 3 | |
Completed |
NCT03682419 -
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)
|
N/A | |
Not yet recruiting |
NCT04981327 -
The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis
|
Phase 3 | |
Recruiting |
NCT03240120 -
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
|
Phase 3 |